Within-group effect size benchmarks for cognitive–behavioral therapy in the treatment of adult depression. Soc Work Res. 2017;41(3):135-144. doi:10.1093/swr/svx011 Google ScholarCrossref 58. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and ...
may benefit individuals with cancer and major depression. Trial participants treated with psilocybin not only experienced a lessening of depressive symptoms but also spoke highly of the therapy when interviewed at the end of the trial. The findings...
截至2022年7月13日,pubmed中使用了"psilocybin","depression"和"mdd"作为搜索词.除了大量的综述文章,人群分析和意见论文外,我们还确定了三项研究裸盖菇素治疗重度抑郁症疗效的试验:一项开放标签试验,一项等待名单对照随机对照试验和一项比较裸...
Clinical trial results show that psilocybin, a potent psychedelic, has antidepressant effects in patients with depression and is more effective than escitalopram. Functional MRI experiments revealed a decrease in brain modularity after psilocybin therapy, indicative of an increase in the global integration...
A single 25 mg dose of psilocybin, the active ingredient in magic mushrooms, has a significant effect on reducing symptoms of depression in people who have so far not benefited from treatment, trial results have shown.1 Researchers investigated the effects of single doses of 25 mg, 10 mg, ...
After comparing the long-term effects of the psychedelic psilocybin and a commonly prescribed antidepressant, new research found that both significantly reduced depression. However, psilocybin provided something more: a significant boost to quality of li
published in the New England Journal of Medicine, all had treatment-resistant depression, meaning they had tried at least two approved depression therapies that afforded them no relief. So any response in a significant number of patients is promising, though the effects were not as long...
In November 2019, the FDA designated psilocybin therapy as a "breakthrough therapy" for depression to the Usona Institute, an action the agency uses to speed up development and review of investigational drugs. Breakthrough therapies are expected to provide a major improvement over currently available...
In this issue ofJAMA Psychiatry, Davis and colleagues1at the Johns Hopkins Center for Psychedelic and Consciousness Research have contributed a timely and important proof-of-concept randomized clinical trial on the effects of psilocybin-assisted supportive psychotherapy for the treatment of major depressi...
BACKGROUND Psilocybin,a naturally occurring psychedelic compound found in certain species of mushrooms,is known for its effects on anxiety and depression.I... H Bader,H Farraj,J Maghnam,... - 《World Journal of Clinical Oncology》 被引量: 0发表: 2024年 [The toxicological aspects of poisoning...